“HTA implementation in Greece: A 3 years’ experience from the industry perspective”

Olympios Papadimitriou, President, Hellenic Association of Pharmaceutical Companies (SFEE)
Download the presentation
Vasilios Pentafragas, Executive Director, Panhellenic Pharmaceutical Association (PEF)
Download the presentation
Agata Jakoncic, President, Pharma Innovation Forum (PIF)
Download the presentation

“HTA implementation in Greece: Patients’ Association perspective”

Georgios Tsiakalakis, Director, Hellenic Patients Association (EAE)
Download the presentation

“Challenges, hurdles, and opportunities for an efficient HTA implementation in Greece”

Flora Bacopoulou, President of the HTA Committee, Associate Professor of Pediatrics – Adolescent Medicine, National and Kapodistrian University of Athens
Download the presentation

“Elements and Observations from HTA and Negotiation committee operations”

Panos Stafylas, MD, MSc, PhD, Cardiologist / HTA Consultant, Scientific Director of HealThink PC, Greece
Download the presentation

“Assessing the added value of new technologies”

Maria Kalogeropoulou, HTA Senior Consultant, IQVIA
Download the presentation

“Identifying the right treatment for the right patient: reimbursement of biomarkers and genomic sequencing”

Angeliki Angeli, Chief Portfolio Value Officer, Roche
Download the presentation

“Do we need special processes to appraise treatments for rare diseases?”

Elena Nicod, Associate Director at Dolon, PhD Centre for Research on Health and Social Care Management (CERGAS), Bocconi University
Download the presentation

“Tapping into resources to strengthen the Value of Evidence for HTA Submissions in Greece”

Myrsini Ouzounelli, MD MBA MPH. CEO, MYO Health
Download the presentation

“The future of HTA relies on the Member state cooperation”

Panos Kanavos, PhD, Associate Professor, Deputy Director, LSE Health, Department of Social Policy, London School of Economics
Download the presentation

“Priority setting, Horizon scanning and joint assessments/ negotiations to ensure sustainable access to innovative medicines: The BENELUXA experience”

Francis Arickx, Advisor at RIZIV-INAMI, Country Coordinator of Belgium for the Beneluxa Initiative
Download the presentation

“European collaborations on patient access to medicines – Lessons learned and implications for national pricing policies such as external price referencing”

Sabine Vogler, Head of the Pharmacoeconomics Department, Head of WHO Collaborating Centre for Pharmaceutical Pricing and Reimbursement Policies, Austrian Public Health Institute
Download the presentation

“Gene Therapies: Is Europe Ready to Value and Reimburse the Next Medical Frontier”

Michael Drummond, MCom, DPhil, Professor of Health Economics, University of York, United Kingdom
Download the presentation

“What is the future of managed entry agreements in the digital health era?”

Katarzyna Kolasa, Professor Kozminski University, Head of Health Economics and Healthcare Management Division
Download the presentation

“Budget impact and thresholds as barriers for funding innovation”

Athanasios Vozikis, Associate Professor, Director of the Laboratory of Health Economics and Management, University of Piraeus, Department of Economics
Download the presentation

“Risk sharing and time to Access for Innovation”

Ilias Kontoudis, Head of Market Access, Bayer Hellas
Download the presentation